Outlook Therapeutics names Kevin Lundquist CFO
Bitget2026/10/06 13:20Outlook Therapeutics appointed Kevin Lundquist as chief financial officer as it shifts to a commercial-stage launch of LYTENAVA. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Outlook Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610060920PRIMZONEFULLFEED9839969) on October 06, 2026, and is solely responsible for the information contained therein.
- Outlook Therapeutics appointed Kevin Lundquist as chief financial officer as it shifts to a commercial-stage launch of LYTENAVA.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Dom Kwok to XRP Army: Why Are Prices Down Despite So Much Bullish News
Brent commands a war premium as Middle East supply risks keep oil on edge
CFTC Chairman claims ‘we will go to war with the statute we’ve got’ as CLARITY Act fails
NASDAQ TRADE HALT CONTINUES <UCFIW.O> REASON NOT AVAILABLE AT 07:50 PM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 07:50 PM
Crypto prices
More
